ABL BIOTEC A/S: Financial statements 2015
CVR: 50811018
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -122,431 and a net result of DKK 2,230,370 compared with DKK 3,774,071 the year before. Equity in the 2015 report amounted to DKK 24,842,691. The solvency ratio was 99.5%.
- Gross Profit
- DKK -122,431
- Profit/Loss
- DKK 2,230,370
- Equity
- DKK 24,842,691
- Total Assets
- DKK 24,969,295
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -122 t. | 2.2 mio. | 24.8 mio. | - |
| 2014 | - | -100 t. | 3.8 mio. | 23.7 mio. | - |
| 2013 | - | -97 t. | 2.7 mio. | 22.4 mio. | - |
| 2012 | - | -51 t. | 3.7 mio. | 21.5 mio. | - |
Official annual report
How creditworthy is ABL BIOTEC A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
ABL BIOTEC A/S has published its annual report for 2014. Gross profit came to DKK -100,370, and the net result was DKK 3,774,071.
About ABL BIOTEC A/S
ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.